Europe Medical Second Opinion Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The European medical second opinion market is projected to grow significantly, reaching approximately USD 4.71 billion by 2031, up from USD 1.65 billion in 2023, with a compound annual growth rate (CAGR) of 14.0% during the forecast period.

Executive Summary and Market Analysis

The growth of the medical second opinion market in Europe is driven by several factors, including the rising incidence of chronic diseases and an increase in healthcare fraud cases. The market benefits from a favorable regulatory environment, the presence of local players, and a growing number of clinics that offer second-opinion services.

Market Segmentation

The market can be segmented based on medical conditions and service providers.

1. By Condition: The market is divided into several categories, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.

2. By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. In 2023, hospitals held the largest share of this segment.

Market Outlook

Medical second opinions are crucial for providing patients with comprehensive information regarding their treatment options. They help clarify the confusion that may arise from multiple treatment recommendations for a single condition. Additionally, obtaining a second opinion can validate diagnoses, thereby enhancing treatment accuracy. The emphasis on improving treatment outcomes is a significant driver of market growth. Given the potential adverse effects of various treatments, obtaining a second opinion from a qualified healthcare professional is essential, especially in critical cases. According to the World Health Organization (WHO), unsafe medical practices contribute to over 3 million deaths annually worldwide. In 2022, approximately 9.7 million cancer-related deaths were reported globally, highlighting the urgent need for accurate diagnoses and effective treatment options. The increasing prevalence of cancer and other chronic diseases is a key factor propelling the demand for medical second opinions.

Country Insights

The European medical second opinion market includes several countries, notably Germany, the UK, France, Italy, Spain, and others. Germany was the leading market in 2023.

In Germany, the market is expected to expand significantly due to the rising rates of chronic diseases, particularly cancer, which is a leading cause of morbidity and mortality. The WHO reported 628,519 new cancer cases and 252,065 cancer-related deaths in Germany in 2020. This alarming trend has led to a heightened demand for accurate diagnostics and treatment options, prompting cancer patients to seek second opinions more frequently.

The German government has recognized the importance of second opinions in healthcare. The "Charter of Patients' Rights in Germany" ensures that patients have the right to seek a second medical opinion, mandating that healthcare providers cooperate with such requests. Notable healthcare providers in Germany, such as IMC Intermed-Consult, offer comprehensive services for international patients seeking second opinions. Additionally, Germany Health provides evaluations from independent medical experts for various conditions, including cancer and orthopedic surgeries.

Local market players are also contributing to the growth of the medical second opinion market in Germany. For instance, the Clinic of Friedrichshafen has introduced a tele-counseling service that allows international patients to access valuable information and alternative treatment options affordably.

Company Profiles

Key players in the European medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe medical second opinion market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Europe medical second opinion market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the medical second opinion market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.